Clinical Trials List
Protocol NumberMK5172 PN012-00
2012-02-01 - 2013-12-31
Phase II
Terminated3
-
Trial Applicant
Merck Sharp & Dohme (I.A.) LLC
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 蘇東弘 Division of General Internal Medicine
- 楊宏志 Division of General Internal Medicine
- Chun-Jen Liu Division of General Internal Medicine
- PEI-JER CHEN Division of General Internal Medicine
- Chen-Hua Liu Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- Chao-Wei Hsu Digestive System Department
- Yi-Cheng Chen Digestive System Department
- Ming-Ling Chang Digestive System Department
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- Chia-Yen Dai Digestive System Department
- Ming-Lun Yeh Digestive System Department
- Jee-Fu Huang Digestive System Department
- Ming-Lung Yu Digestive System Department
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
12 participants
-
Global
120 participants
